Recurrent Melanoma Active Not Recruiting Phase 1 Trials for Cabozantinib (DB08875)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01709435Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsTreatment